Evidence map›Paper›PMID 38633987›Full record

ArticleFrontiers in chemistry2024

Quantum-assisted fragment-based automated structure generator (QFASG) for small molecule design: an

Sergei Evteev, Yan Ivanenkov, Ivan Semenov, Maxim Malkov, Olga Mazaleva, Artem Bodunov, Dmitry Bezrukov, Denis Sidorenko, Victor Terentiev, Alex Malyshev and 4 more

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sergei EvteevInsilico Medicine Hong Kong Ltd., Hong Kong, Hong Kong SAR, China.
Yan IvanenkovInsilico Medicine Hong Kong Ltd., Hong Kong, Hong Kong SAR, China.
Ivan SemenovInsilico Medicine Hong Kong Ltd., Hong Kong, Hong Kong SAR, China.
Maxim MalkovInsilico Medicine AI Limited, Abu Dhabi, United Arab Emirates.
Olga MazalevaInsilico Medicine Hong Kong Ltd., Hong Kong, Hong Kong SAR, China.
Artem BodunovInsilico Medicine Hong Kong Ltd., Hong Kong, Hong Kong SAR, China.
Dmitry BezrukovInsilico Medicine AI Limited, Abu Dhabi, United Arab Emirates.
Denis SidorenkoInsilico Medicine Hong Kong Ltd., Hong Kong, Hong Kong SAR, China.
Victor TerentievInsilico Medicine Hong Kong Ltd., Hong Kong, Hong Kong SAR, China.
Alex MalyshevInsilico Medicine Hong Kong Ltd., Hong Kong, Hong Kong SAR, China.
Bogdan ZagribelnyyInsilico Medicine AI Limited, Abu Dhabi, United Arab Emirates.
Anastasia KorzhenevskayaInsilico Medicine Hong Kong Ltd., Hong Kong, Hong Kong SAR, China.
Alex AliperInsilico Medicine AI Limited, Abu Dhabi, United Arab Emirates.
Alex ZhavoronkovInsilico Medicine AI Limited, Abu Dhabi, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ATMCAMKK2computer-assisted drug designde novo designfragment-based drug designkinase inhibitorsmolecular modelingxTB

Identifiers

PMID38633987
PMCPMC11021760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.